Colors: Tranquility IX

I’m publishing this series on LinkedIn called Colors to explore a topic that I care deeply about: the Renaissance Mind. I am just as passionate about entrepreneurship, technology, and business, as I am about art and culture. In this series, I will typically publish a piece of art – one of my paintings – and I request you to spend a minute or two deeply meditating on it. I urge you to watch your feelings, thoughts, reactions to the piece, and write what comes to you, what thoughts it triggers, in the dialog area. Let us see what stimulation this interaction yields. For today – Tranquility IX

Tranquility IX | Sramana Mitra, 2022 | Watercolor, Pastel, Ink | 8 x 8, On Paper

Featured Videos

Colors: Tranquility VIII

I’m publishing this series on LinkedIn called Colors to explore a topic that I care deeply about: the Renaissance Mind. I am just as passionate about entrepreneurship, technology, and business, as I am about art and culture. In this series, I will typically publish a piece of art – one of my paintings – and I request you to spend a minute or two deeply meditating on it. I urge you to watch your feelings, thoughts, reactions to the piece, and write what comes to you, what thoughts it triggers, in the dialog area. Let us see what stimulation this interaction yields. For today – Tranquility VIII

Tranquility VIII | Sramana Mitra, 2022 | Watercolor, Pastel, Ink | 8 x 8, On Paper

1Mby1M Virtual Accelerator Investor Forum: With Julien Pham, 3CC Third Culture Capital (Part 6)

Sramana Mitra: I’m asking a simpler question. Are these all B to B companies – businesses selling to hospitals or insurance companies or pharmaceutical companies?

Julien Pham: Oh, we do a little bit of everything. We have a few B to C, B to B, or B to B to C companies because end user oftentimes is the patient. If you remember, one of our important screening criteria of the quintuple aim is, how does it improve outcomes for patients? So we want to make sure that it somehow touches patients.

Video FAQs

July 18 – 646th 1Mby1M Mentoring Roundtable for Entrepreneurs

Entrepreneurs are invited to the 646th FREE online 1Mby1M Mentoring Roundtable on Thursday, July 18, 2024, at 8 a.m. PDT / 11 a.m. EDT / 5 p.m. CEST / 8:30 p.m. India IST.

If you are a serious entrepreneur, register to “pitch” and sell your business idea. You’ll receive straightforward feedback, advice on next steps, and answers to any of your questions. Others can register to “attend” to watch, learn, and interact through the online chat.

You can learn more here and REGISTER TO PITCH OR ATTEND HERE. Register and you will receive the recording by email, even if you are unable to attend. Please share with any entrepreneurs in your circle who may be interested. All are welcome!

645th 1Mby1M Entrepreneurship Podcast with Ashmeet Sidana, Engineering Capital

Ashmeet Sidana, Chief Engineer at Engineering Capital, talks about his AI investment thesis. It’s a wonderful discussion that not only entrepreneurs should listen to, but investors should also listen in to calibrate their own investment thesis.

Podcast: Play in new window | Download

Subscribe: Apple Podcasts | Android | Google Play | Stitcher | TuneIn | RSS

645th 1Mby1M Roundtable Recording

In case you missed it, you can listen to the recording of this roundtable here:

Roundtable Recap: July 11 – AI Investment Thesis Discussion with Ashmeet Sidana, Engineering Capital

During this week’s roundtable, we had as our guest Ashmeet Sidana, Chief Engineer at Engineering Capital. It’s a wonderful discussion that not only entrepreneurs should listen to. Investors must also listen to it to calibrate their own investment thesis.

You can listen to the recording of this roundtable here:

>>>

IPOs 2024: Tempus AI Addresses Medical Diagnostic Use Case

According to a market report, the use of AI in medical diagnostics is expected to grow at 25% CAGR from $0.8 billion in 2022. Chicago-based Tempus AI (Nasdaq: TEM) is a leading player in the market that recently went public to a weak market response.